| Name | Title | Contact Details |
|---|
CS Medical is a Raleigh, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
ChoiceSpine, LP was founded in December of 2006 in Knoxville, TN. The company is designed to take to the market technically-superior spinal products through a service-focused distribution network. The management team of ChoiceSpine has more than 70 years of industry experience in the areas of research and development, engineering and manufacturing, distribution and sales, financial management and administration. Rick Henson and Marty Altshuler are co-founders and executives of the corporation. They have extensive knowledge of the orthopedic and spinal markets. They are co-principals of ChoiceSpine. They have worked together for 20 years in creating successful healthcare businesses. ChoiceSpine acquired Orthotec, a 40 million dollar company, and now holds the exclusive rights for the U.S. market, several patents and 6 specific spinal conditions. These innovative and proprietary products, when combined with effective procedures, have a successful track record of producing better quality outcomes in surgical patients.
TearLab Corporation develops and commercializes lab-on-a-chip technologies that enable eye care practitioners to improve standard of care by quantitatively testing for disease markers in tears at the point-of-care. Headquartered in San Diego, CA, TearLab Corporation`s common shares trade on the NASDAQ Capital Market under the symbol `TEAR` and on the Toronto Stock Exchange under the symbol `TLB`. Dry Eye Disease (DED) is a chronic, progressive disease. Morgan Stanley’s Dry Eye Market Report (2003) estimates that 30 to 60 million Americans suffer from dry eye symptoms. Only 10 million are diagnosed with the disease. Millions more suffer worldwide. The TearLab™ Osmolarity System provides the first quantitative and objective diagnostic technology that allows doctors to effectively manage their dry eye patients. TearLab will allow practitioners to diagnosis DED patients early in the disease process allowing for early intervention. TearLab received the CE Mark for its TearLab Osmolarity System in 2008 and FDA Clearance in 2009. TearLab is currently marketed globally in more than 14 countries including the US.
Euro Dental Implant is a San Francisco, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
EBT Medical was founded in 2014 with a mission to develop novel neuromodulation technologies which restore control, dignity and independence to those silently suffering from pelvic floor disorders.